Essential Partners’s Amicus Therapeutics FOLD Stock Holding History

Essential Partners’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-793	Closed	-$11.5K	–	2895
2026 Q1	$11.5K	Hold	793	–	–	﹤0.01%	1184
2025 Q4	$11.3K	Buy	793 +216	+37%	+$2.12K	﹤0.01%	1127
2025 Q3	$4.55K	Buy	+577	New	+$4.11K	﹤0.01%	1459

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Essential Partners's FOLD Position: Q2 2026 in Review

Essential Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 793 shares — an estimated $11.5K sold.

Essential Partners first reported a position in FOLD in Q3 2025 and held it in 3 quarters. The position peaked at $11.5K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Essential Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Essential Partners sold 793 Amicus Therapeutics shares in Q2 2026, an estimated $11.5K.
Essential Partners first reported a position in Amicus Therapeutics in Q3 2025 and held it in 3 quarters.
Essential Partners's Amicus Therapeutics position peaked at $11.5K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.